NCT00723775View on ClinicalTrials.gov

GSK706769/KALETRA Drug-drug Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

July 24, 2008

Primary Completion Date

November 8, 2008

Study Completion Date

November 8, 2008

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

GSK706769 & KALETRA

GSK706769 alone and GSK706769 + Kaletra

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY